HomeTWST • NASDAQ
add
Twist Bioscience Corp
Previous close
$39.50
Day range
$37.46 - $39.67
Year range
$27.41 - $60.90
Market cap
2.28B USD
Avg Volume
1.27M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Founded
2013
Website
Employees
923